TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...
TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...
GlobalData on MSN8h
MHRA seeks input on new regulatory guidance for cancer vaccinesThe proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
KBR announced today its participation in upcoming February 2025 investor conferences. TD Cowen 46th Annual Aerospace and ...
MIAMI, Feb. 3, 2025 /PRNewswire-PRWeb/ -- kluster.ai, the decentralized AI platform, became the first to market to host DeepSeek-R1. The model matches OpenAI's performance in logic, mathematics, and ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback